截至2026年1月5日收盘，港通医疗(301515)报收于22.9元，上涨14.16%，换手率14.81%，成交量9.71万 手，成交额2.18亿元。 董秘最新回复 1月5日主力资金净流入1522.34万元；游资资金净流入71.39万元；散户资金净流出1593.73万元。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 董秘： 尊敬的投资者，您好！公司截至2025年12月31日股东总户数为7415户，感谢您的关注。 当日关注点 来自交易信息汇总：1月5日主力资金净流入1522.34万元，显示主力对港通医疗的积极介入。 交易信息汇总资金流向 投资者： 请问截至2025年12月31日，公司股东人数是多少？ 董秘： 尊敬的投资者，您好！公司截至2025年12月31日股东总户数为7415户，感谢您的关注。 投资者： 你好，作为贵公司的中小投资者，截止12月31日的股东人数是多少人，谢谢！ ...

Group 1 - The Shanghai Composite Index is at 4005.73 points, above the annual line, with an increase of 0.93% [1] - The total trading volume of A-shares today is 1,402.986 billion yuan [1] - A total of 154 A-shares have surpassed the annual line, with notable stocks showing significant deviation rates including Yingkang Life, Gangtong Medical, and Beilu Pharmaceutical at 10.63%, 10.61%, and 9.97% respectively [1] Group 2 - The top three stocks with the highest deviation rates from the annual line are: - Yingkang Life (12.85% increase, 10.63% deviation) - Gangtong Medical (11.91% increase, 10.61% deviation) - Beilu Pharmaceutical (10.20% increase, 9.97% deviation) [1] - Other notable stocks with significant increases include: - Guanhao Biological (14.87% increase, 8.29% deviation) - Baichu Electronics (6.95% increase, 6.79% deviation) [1] - Stocks with smaller deviation rates that have just crossed the annual line include *ST Yedao, Shiyan Institute, and Shanxi Securities [1]

Group 1 - The core viewpoint of the news is that 港通医疗 (Kangtong Medical) has shown a mixed performance in terms of financing and stockholder metrics, with a notable decrease in revenue and profit in recent periods [1][2]. Group 2 - As of December 31, 港通医疗's stock price increased by 0.30%, with a trading volume of 18.21 million yuan [1]. - The financing data indicates that on the same day, 港通医疗 had a financing buy amount of 1.00 million yuan and a financing repayment of 1.77 million yuan, resulting in a net financing buy of -0.77 million yuan [1]. - The total financing and margin trading balance for 港通医疗 reached 28.46 million yuan, which is 2.03% of its circulating market value, indicating a low financing balance compared to the past year [1]. Group 3 - 港通医疗's main business involves providing medical institutions with overall solutions centered on medical gas systems and clean operating rooms, with revenue contributions of 55.69% from clean equipment and systems, 37.30% from medical gas equipment and systems, and 4.06% from other medical equipment sales [1]. - As of December 19, the number of shareholders for 港通医疗 increased to 7,539, while the average circulating shares per person decreased to 8,362 shares [2]. - For the period from January to September 2025, 港通医疗 reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to the parent company of -10.21 million yuan, a year-on-year decrease of 150.92% [2]. Group 4 - 港通医疗 has distributed a total of 48.99 million yuan in dividends since its A-share listing [3]. - As of September 30, 2025, the top ten circulating shareholders included 诺安多策略混合A (Noah Multi-Strategy Mixed A), which holds 725,100 shares as a new shareholder [3].

Group 1 - The core viewpoint of the article highlights the financial performance and stock activity of Kangtong Medical (301515) as of December 30, 2025, showing a decline in stock price and mixed capital flow [1][2] - Kangtong Medical reported a main revenue of 344 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 30.06% [2] - The company experienced a net profit loss of 10.21 million yuan for the same period, with a significant year-on-year decline of 150.92% [2] Group 2 - In Q3 2025, Kangtong Medical's quarterly main revenue was 79.12 million yuan, reflecting a year-on-year increase of 42.81% [2] - The company's net profit for Q3 2025 was a loss of 1.80 million yuan, down 138.94% year-on-year [2] - The debt ratio of Kangtong Medical stands at 40.94%, with a gross profit margin of 22.45% [2]

Group 1 - The core index of the Shenzhen-Hong Kong Stock Connect Medical Index (983035) closed at 4400.67 points, down 0.84%, with a trading volume of 9.364 billion yuan and a turnover rate of 0.96% [1] - Among the constituent stocks, 8 stocks increased, with Aidi Te leading with a rise of 3.21%, while 48 stocks decreased, with Baize Medical leading the decline at 6.52% [1] - The net outflow of main funds from the Shenzhen-Hong Kong Stock Connect Medical Index constituents totaled 390 million yuan, while retail investors saw a net inflow of 497 million yuan [2] Group 2 - The Shenzhen-Hong Kong Stock Connect Medical Index made adjustments in the last 10 days, adding 2 new stocks to its constituents [2]

Group 1 - The core index of the Shenzhen-Hong Kong Stock Connect Medical Index (HKD) closed at 4355.33 points, down 0.53%, with a trading volume of 10.417 billion HKD and a turnover rate of 0.96% [1] - Among the constituent stocks, 8 stocks increased, with Aidi Te leading with a 3.21% rise, while 48 stocks decreased, with Baize Medical leading the decline at 6.52% [1] - The net outflow of main funds from the constituent stocks totaled 390 million HKD, while retail investors saw a net inflow of 497 million HKD [2] Group 2 - The Shenzhen-Hong Kong Stock Connect Medical Index has made adjustments in the last 10 days, incorporating 2 new stocks [2]

Group 1 - The core viewpoint of the news is that 港通医疗 (Kangtong Medical) is experiencing a decline in stock performance and financial metrics, with significant decreases in revenue and net profit reported for the year [1][2] - As of December 26, 港通医疗's stock price fell by 1.17%, with a trading volume of 17.42 million yuan, and a net financing purchase of 126,600 yuan [1] - The company's financing balance is 29.31 million yuan, accounting for 2.08% of its market capitalization, which is below the 10th percentile level over the past year, indicating a low financing level [1] Group 2 - For the period from January to September 2025, 港通医疗 reported a revenue of 344 million yuan, a year-on-year decrease of 30.06%, and a net profit attributable to shareholders of -10.21 million yuan, a decline of 150.92% [2] - The company has distributed a total of 48.99 million yuan in dividends since its A-share listing [3] - As of September 30, 2025, the number of shareholders for 港通医疗 increased by 2.5% to 7,539, while the average circulating shares per person decreased by 2.44% to 8,362 shares [2][3]

Group 1 - The core index of the Shenzhen-Hong Kong Stock Connect Medical Index (983035) closed at 4447.92 points, with a slight increase of 0.17% and a trading volume of 8.188 billion yuan, resulting in a turnover rate of 1.02% [1] - Among the constituent stocks, 31 companies experienced an increase, with MicroPort Medical leading the gain at 4.91%, while 22 companies saw a decline, with Yimai Sunshine leading the drop at 3.96% [1] Group 2 - The net outflow of main funds from the Shenzhen-Hong Kong Stock Connect Medical Index constituents totaled 154 million yuan, while retail investors saw a net inflow of 232 million yuan [2] - Over the past 10 days, there have been adjustments in the constituent stocks of the Shenzhen-Hong Kong Stock Connect Medical Index, with 2 new stocks added [2]

Group 1 - The core index of the Shenzhen-Hong Kong Stock Connect Medical Index closed at 4383.64 points, with a gain of 0.28% and a trading volume of 9.071 billion HKD, resulting in a turnover rate of 1.02% [1] - Among the constituent stocks, 31 stocks increased, with MicroPort Medical leading the gain at 4.91%, while 22 stocks decreased, with Yimai Sunshine leading the decline at 3.96% [1] - The net outflow of main funds from the Shenzhen-Hong Kong Stock Connect Medical Index constituents totaled 154 million HKD, while retail investors saw a net inflow of 232 million HKD [2] Group 2 - The Shenzhen-Hong Kong Stock Connect Medical Index has made adjustments in the last 10 days, adding 2 new stocks to its constituents [2]

Group 1 - The core index of the Shenzhen-Hong Kong Stock Connect Medical Index (HKD) closed at 4370.16 points, down 0.94%, with a trading volume of 10.39 billion HKD and a turnover rate of 1.31% [1] - Among the constituent stocks, 11 stocks rose, with Furuimei Medical leading with a 2.4% increase, while 48 stocks fell, with Baize Medical leading the decline at 6.11% [1] - The net outflow of main funds from the constituent stocks amounted to 646 million HKD, while retail funds saw a net inflow of 606 million HKD [2] Group 2 - The Shenzhen-Hong Kong Stock Connect Medical Index has made adjustments in the last 10 days, adding 2 new stocks to its constituents [2]